New challenges in therapeutic vaccines against HIV infection.

about

Immune Checkpoints in Leprosy: Immunotherapy As a Feasible Approach to Control Disease Progression.RNA Interference Therapies for an HIV-1 Functional Cure.Phase I clinical trial of an intranodally administered mRNA based therapeutic vaccine against HIV-1 infection

P2860

Q47221330-A833BC48-EE9D-4A1C-8288-BF850BE4C85C Q47252129-D3791CD8-A26D-4F86-84D2-07CAAA5BBAE0 Q57023723-72E481F9-CF6B-47FD-8C96-0F6C4192D508

P2860

New challenges in therapeutic vaccines against HIV infection.

Item

http://www.wikidata.org/entity/Q38692205

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

New challenges in therapeutic vaccines against HIV infection.

@en

type

Item

label

New challenges in therapeutic vaccines against HIV infection.

@en

prefLabel

New challenges in therapeutic vaccines against HIV infection.

@en

P1476

New challenges in therapeutic vaccines against HIV infection

@en

P2093

Constanza Lucero

http://www.w3.org/2001/XMLSchema#string

Josep M Gatell

http://www.w3.org/2001/XMLSchema#string

Lorna Leal

http://www.w3.org/2001/XMLSchema#string

Montserrat Plana

http://www.w3.org/2001/XMLSchema#string

Teresa Gallart

http://www.w3.org/2001/XMLSchema#string

P2860

Design and pre-clinical evaluation of a universal HIV-1 vaccine

Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions

T-cell therapies for HIV

Immunopathogenesis and immunotherapy in AIDS virus infections

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel

Restoring function in exhausted CD8 T cells during chronic viral infection

Immunotherapy with canarypox vaccine and interleukin-2 for HIV-1 infection: termination of a randomized trial

Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART

DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus

P304

587-600

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14760584.2017.1322513

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Felipe García

P577

2017-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28431490

http://www.w3.org/2001/XMLSchema#string

New challenges in therapeutic vaccines against HIV infection.

about

P2860

P2860

New challenges in therapeutic vaccines against HIV infection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698